Business Wire

BridgeTower Capital Partners with Global Industry-Leading Art Fund Artemundi to Release NFT Series of Master Spanish Artist Francisco Goya

Share

BridgeTower Capital, an innovator in connecting blockchain markets globally, announced a partnership with Artemundi, a leading global art fund, to release a series of NFTs featuring the work of acclaimed Spanish artist Francisco Goya. The announcement was made at the Avalanche Summit this week in Barcelona, where all live attendees received the NFT of Goya’s Caprice No. 6 titled, “No One Knows Each Other.”

“Francisco Goya is frequently recognized for his ability to portray the human condition and we believe this series of NFTs are a unique opportunity to bring the work of this Spanish Master to an entirely new audience for appreciation,” said Artemundi Chief Executive Officer Javier Lumbreras. “Goya’s work transcends time. This piece – Caprice No. 6 – shines light on our ability to effectively connect with each other. This has never been more relevant today and is at the core of our society within the expanding Metaverse.”

Caprice No. 6 is the first of a series of Goya NFTs that will be released over the next year and will be selected from 80 Caprices owned by Artemundi. Each will include an introduction about Goya, a description and translation title for all countries and a short, formal description of the symbolism of the piece. The NFTs will reside in the BridgeTower Permissioned Market, that investors can enter by creating a Securitize iD for a seamless KYC process that can be carried out in minutes. Securitize is a global leader in compliant issuance of digital assets and securities.

“It is an honor for BridgeTower to participate in this partnership with Artemundi celebrating the work of Francisco Goya,” said BridgeTower CEO Cory Pugh. “The BridgeTower Permissioned Market is a perfect place for these NFTs to reside and to create – through smart contracts within the Market – the proper asset ownership and authority for the investor.”

One of the most important elements of the Goya NFT collection will be the opportunities created for new and deeper interactions with a community of appreciation for Goya’s work. Discussion Forums will be built to discuss 21st Century interpretation of the Caprices, discussion of artistic expression, language, qualitative and subjective value of the Caprice. Additionally, a “how to see and appreciate your Goya Caprice” will be excerpted from the book The Art of Collecting Art, written by Javier Lumbreras.

The 21st Century relevance of the Goya masterpieces offer compelling themes that could be taken from today’s headlines. In addition to the Metaverse, upcoming Goya NFTs will feature themes including gender inequality, demagogue/fake news, freedom and the events in Ukraine.

“NFTs are just an incredible opportunity to participate in art in the 21st century,” continued Lumbreras. “It truly is a once-in-a-lifetime opportunity and we’re thrilled to be a part of this partnership between Artemundi and BridgeTower Capital.”

About BridgeTower Capital

BridgeTower Capital has developed a global platform to uniquely bring products to its own permissioned markets to seamlessly enable an institutional gateway to staking, DeFi, NFT and Web 3.0 entities. BridgeTower operates more than 5,000 of its own staking nodes and owns servers utilizing 100 percent renewable energy. Significant portions of returns from these products are reinvested to continually grow BridgeTower’s infrastructure and assets. BridgeTower is a global company based in Singapore with operating entities in Switzerland and the United States allowing it to compliantly address many of the most important jurisdictions in the global economy.

Learn more at http://www.bridgetowercapital.com.

About Artemundi

Artemundi was born out of a rebellious idea and a principled objective: to help their clients build and diversify their art investments without the excessive fees associated with traditional brick-and-mortar art companies while adhering to transparent business practices. Since its foundation in 1989, Artemundi has evolved into an industry-leading art investment company with thousands of successful transactions and over a billion dollars managed in art.

Learn more at https://artemundi.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contacts
BridgeTower: Todd Wolfenbarger, todd@bridgetowercapital.com
Artemundi: Daniel Fabris, Daniel.fabris@artemundi.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

US Streaming Technology Giant Conviva Launches Full-Scale Continuous Measurement Analytics in Japan18.5.2022 04:00:00 EEST | Press release

Conviva (Headquartered at Foster City, California, USA; Japan Office: Chiyoda-ku, Tokyo; hereinafter referred to as Conviva or the Company), which provides continuous measurement analytics through real-time, server side sessionization of video streaming data, today announced the opening of the Japan office, which will serve as a base for sales and customer support in the rapidly-growing Japanese market. The Company also released a current State of Streaming Report for Japan highlighting key streaming trends in the market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220517006275/en/ Conviva State of Streaming Japan Report (Graphic: Business Wire) “Conviva invented continuous measurement analytics for streaming video and has been driving the development of the global market including Japan with over 58 technology patents over the past decade,” comments Conviva CEO Keith Zubchevich. “Today, we are pleased to announce the est

Starr Insurance Companies Expands in Thailand17.5.2022 23:33:00 EEST | Press release

Starr Insurance Companies (Starr) announced an agreement with FPG Insurance Holdings Limited (HK) (FPG) and local Thai shareholders to purchase FPG Insurance Public Company Limited (FPG Thailand), a Thai non-life insurance company, together with local Thai parties. Starr’s investment will be held by its Bermuda insurance company, Starr Insurance & Reinsurance Limited. The transaction is expected to close in the second quarter of 2022, subject to certain customary closing conditions, including any necessary regulatory approvals. “Thailand is an important, fast-growing insurance market — one of the cornerstones of the Southeast Asia economy,” said Maurice R. Greenberg, Starr’s Chairman & CEO. “Asia is both commercially and culturally important to Starr, as we trace our roots to an American-owned company founded in Shanghai more than 100 years ago. We look forward to serving the needs of local Thai companies and consumers through this new insurance capability.” David Zuellig, FPG regional

Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE-related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting17.5.2022 23:15:00 EEST | Press release

Emendo Biotherapeutics presented the results of its next generation CRISPR-based gene editing approaches for several indications in an oral presentation and three posters at the 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) held May 16-19, 2022, in Washington, D.C. Emendo presented pre-clinical data for the treatment of ELANE-related Severe Congenital Neutropenia using an allele-specific editing approach, demonstrating the power of Emendo’s dual technology platforms that enable the development of a highly specific editing composition that demonstrates no off-targets and complete allele specificity. Significantly, the lack of off-target achieved by Emendo’s engineered and optimized OMNI nuclease also eliminated any translocations. Edited patient derived CD34+ cells differentiated normally into neutrophils both in-vitro and in-vivo, showing full engraftment and reconstitution of all blood lineages, as required for the desired therapeutic effect. “ELANE-based

Piper Sandler Advises PETRONAS Chemicals Group Berhad on Acquisition of Perstorp17.5.2022 20:59:00 EEST | Press release

Piper Sandler & Co. chemicals investment banking announced today that it has advised PETRONAS Chemicals Group Berhad (PCG) on its acquisition of Perstorp Holding AB. The transaction Enterprise Value is €2,300 million and base purchase price, less adjusted net debt, is €1,538 million. It is expected to close in Q3 2022 subject to customary closing conditions. PCG is the leading integrated chemicals producer in Malaysia and one of the largest in Southeast Asia. It operates a number of world-class production sites, which are fully vertically integrated from feedstock to downstream end-products. With a total combined production capacity of 12.8 million metric tons per annum (mtpa), it is involved primarily in manufacturing, marketing, and selling a diversified range of chemical products, including olefins, polymers, fertilizers, methanol and other basic chemicals and derivative products. Listed on Bursa Malaysia in 2010 and with more than three decades of experience in the chemicals indust

Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for Use of Its Probiotic Bifidobacterium longum BB536 in Infant and Toddler Foods17.5.2022 20:53:00 EEST | Press release

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Bifidobacterium longum BB536 was approved by the National Health Commission (NHC) of the People’s Republic of China as a new food ingredient for use in infant and toddler foods (under the age of three) on 11th May 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220517005112/en/ Morinaga Milk obtains the registration of "New Food Ingredient" in China for use of its probiotic Bifidobacterium longum BB536 in infant and toddler foods on 11th May 2022. (Graphic: Business Wire) Following a complex and lengthy registration process, the probiotic strain B. longum BB536 meets the highest standards of safety and regulatory compliance and has now completed the approval process for use as an ingredient in infant and toddler milk and food products for children under three years old in China. “We are extr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom